Benzmalecene

This classification denotes an anti-lipidemic agent with the molecular formula C20H19Cl2NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6ET4K804XA, chemically known as n-(2,3-bis(p-chlorophenyl)-1-methylpropyl)maleamic acid (alpha-form) but generally known as benzmalecene, which bears US NIH Compound Identifier 6436094. European Medicines Agency schedules Benzmalecene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05752MIG. The term BENZMALECENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). BENZMALECENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzmalecene under HS 29242995 and SITC 51479. As of Q4 2014, BENZMALECENE remains the US FDA Preferred Term for this commodity. Benzmalecene bears US NLM identifiers UMLS ID C0701040 and NCI Concept Code C79818. SMILES: Clc1ccc(C(C(NC(=O)/C=C/C(=O)O)C)Cc2ccc(Cl)cc2)cc1.